Trials / Completed
CompletedNCT00601484
An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis
A PHASE 2, 16 WEEK, MULTICENTER, RANDOMIZED, DOUBLE BLIND PLACEBO CONTROLLED, PARALLEL GROUP PROOF OF CONCEPT STUDY EVALUATING THE EFFICACY AND SAFETY OF PF-04383119 FOR THE TREATMENT OF PAIN ASSOCIATED WITH INTERSTITIAL CYSTITIS
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether PF-04383119 is effective in the treatment of pain associated with interstitial cystitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PF-04383119 | PF-04383119 200 mcg/kg IV, single dose |
| DRUG | Placebo | placebo IV, single dose |
Timeline
- Start date
- 2008-03-17
- Primary completion
- 2009-04-15
- Completion
- 2009-04-15
- First posted
- 2008-01-28
- Last updated
- 2021-05-13
- Results posted
- 2021-05-13
Locations
34 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00601484. Inclusion in this directory is not an endorsement.